Mergers and acquisitions (M&As) are accelerating across healthcare—combining hospitals, physician groups, payers and digital health platforms in pursuit of scale, integrated care and better financial ...
Alumis Inc., a clinical-stage biopharmaceutical company, announced key developments in its pipeline and a merger with ACELYRIN during its recent financial results release. At the AAD 2025 conference, ...
Renasant Corporation and The First Bancshares, Inc. announced they have received all necessary regulatory approvals for their proposed merger, which is set to close on April 1, 2025. This merger will ...
Renasant's $1.2B merger with The First Bancshares expands its Southeastern US footprint, but the full impact remains unclear post-Q2 2025 results. The combined bank now controls $26.6B in assets and ...
Brian Bird, CEO, reported "GAAP diluted EPS of $0.62 per share, non-GAAP diluted EPS of $0.79 per share for the quarter." He affirmed the 2025 earnings guidance range of $3.53 to $3.65 and highlighted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback